Obsessive-Compulsive Disorder Is a Leading Cause of Disability Worldwide, With Causes Not Fully Understood - Katie Charles

Stressed New Yorkers Can Now Seek Care at Mount Sinai’s New Resilience-Focused Medical Practice

Mount Sinai Is First in the Nation to Perform Deep Brain Stimulation Implant as Part of Clinical Trial for Depression

Mount Sinai Opens the Hamilton and Amabel James Center for Artificial Intelligence and Human Health to Transform Health Care by Spearheading the AI Revolution

Mount Sinai Creates Research Center Focusing on Opioids, Emerging Substances, and Drug Overdose

Jean-Laurent Casanova is Recipient of 2023 Maria I. New International Prize for Biomedical Research

Dysregulation of the Brain’s Reward Learning System Is Identified by Scientists as a Potential Driver and Treatment Target for Cocaine Addiction

Decoding Depression: Researchers Identify Crucial Biomarker That Tracks Recovery From Treatment-Resistant Depression

Mount Sinai Launches Institute for Regenerative Medicine

Cocaine Use Disorder Alters Gene Networks of Neuroinflammation and Neurotransmission in Humans

Mount Sinai Receives $2 Million From the Parkinson’s Foundation to Investigate Underlying Cell-Specific Mechanisms of the Condition

Mount Sinai Launches Large-Scale Genetic Sequencing Project with the Regeneron Genetics Center